4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-010658
Chief Scientific Officer sold 5,000 shares at $13.06 ($65,311)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2023-02-15 | Sale | −5,000 | $13.06 | $65,311 | 91,386 | D |
| Open-market sales · 5,000 sh · avg $13.06 · $65,311 | |||||||
Loading xslF345X03/doc4.xml…